Improving representation our clinical trials: HIV
HIV trials have traditionally underrepresented groups who are disproportionately impacted by HIV. Find out how we’re working with the communities most affected by HIV to ensure they are included in our clinical trials.
▶︎
Ahead Together: HIV
▶︎
EP 3: Getting Ahead of HIV together
▶︎
DAMKA – Supporting people living with HIV
▶︎
Biopharm Culture: Delivering innovative biopharm medicines at GSK
▶︎
2026 GSK IMPACT Award Winner - Happy Baby Community
▶︎
Living with asthma and COPD
▶︎
Mapping myelofibrosis podcast episode two| Advocacy in focus
▶︎
Urban Community Clinic – Preventing disease in the community
▶︎
Laboratory for Genomics Research
▶︎
Pneumonia: personal stories, symptoms, and prevention
▶︎
Meet a Mentor Mother helping young mothers living with HIV in Uganda
▶︎
Ep 10: Getting Ahead of HIV/AIDS Together
▶︎
From medicine to biopharma: Meet the talented people who made the transition to GSK
▶︎
Chronic hepatitis B: Claudia and Thomas' story
▶︎
2024 GSK IMPACT UK Awards
▶︎
Ep 12: Getting Ahead of Multiple Myeloma Together
▶︎
Towards NTD elimination: a spotlight on lymphatic filariasis
▶︎
Onyx: building a better data and prediction-powered drug discovery process
▶︎
Science on the Sofa “Driving Innovation in Oncology Cell Therapies”
▶︎